Patents by Inventor Isabelle Callebaut

Isabelle Callebaut has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds for treating cystic fibrosis
    Patent number: 10414768
    Abstract: The present invention relates to compounds of Formula (I) or pharmaceutically acceptable enantiomers, salts, solvates or prodrugs thereof. The invention further relates to the use of the compounds of Formula (I) for the treatment of cystic fibrosis. The invention also relates to a process for manufacturing compounds of Formula (I).
    Type: Grant
    Filed: December 4, 2015
    Date of Patent: September 17, 2019
    Assignees: Centre National de la Recherche Scientifique (CNRS), Université Pierre et Marie Curie—Paris 6 (UPMC)
    Inventors: Isabelle Callebaut, Jean-Paul Mornon, Jean-Luc Decout, Frederic Becq, Pierre Lehn, Brice Hoffman, Benjamin Boucherle, Romain Haudecoeur, Antoine Fortune, Clement Boinot, Julien Alliot
  • COMPOUNDS FOR TREATING CYSTIC FIBROSIS
    Publication number: 20170362239
    Abstract: The present invention relates to compounds of Formula (I) or pharmaceutically acceptable enantiomers, salts, solvates or prodrugs thereof. The invention further relates to the use of the compounds of Formula (I) for the treatment of cystic fibrosis. The invention also relates to a process for manufacturing compounds of Formula (I).
    Type: Application
    Filed: December 4, 2015
    Publication date: December 21, 2017
    Inventors: Isabelle CALLEBAUT, Jean-Paul MORNON, Jean-Luc DECOUT, Frederic BECQ, Pierre LEHN, Brice HOFFMAN, Benjamin BOUCHERLE, Romain HAUDECOEUR, Antoine FORTUNE, Clement BOINOT, Julien ALLIOT
  • Leptin antagonists
    Patent number: 7307142
    Abstract: The invention relates to synthetic leptin antagonists in which at least two amino acid residues of the sequence LDFI/S of the hydrophobic binding site at positions 39-42 of a leptin polypeptide sequence are substituted with different amino acid residues such that the site becomes less hydrophobic, and fragments of said leptin antagonists.
    Type: Grant
    Filed: November 26, 2004
    Date of Patent: December 11, 2007
    Assignees: Yissum Research and Development Company of the Hebrew University of Jerusalem, Universités Paris 6 et Paris 7, Institut Nationale de la Recherche Agronomique (INRA)
    Inventors: Arieh Gertler, Isabelle Callebaut, Jean Djiane
  • Leptin antagonists
    Publication number: 20060154859
    Abstract: The invention relates to synthetic leptin antagonists in which at least two amino acid residues of the sequence LDFI/S of the hydrophobic binding site at positions 39-42 of a leptin polypeptide sequence are substituted with different amino acid residues such that the site becomes less hydrophobic, and fragments of said leptin antagonists.
    Type: Application
    Filed: November 26, 2004
    Publication date: July 13, 2006
    Applicants: Yissum Research Development Company of The Hebrew University of Jerusalem, Universites Paris 6 et Paris 7, Institut Nationale de la Recherche Agronomique (INRA)
    Inventors: Arieh Gertler, Isabelle Callebaut, Jean Djiane